NovoCure Limited (FRA:038)
Germany
· Delayed Price · Currency is EUR 9.84
+0.76 (8.42%)
At close: Dec 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Tumor Treating Fields | 605.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Treating Fields Growth | 18.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| United States | 391.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 12.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | 65.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | 8.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France | 55.73M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 32.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 2.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Greater China | 17.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Greater China Growth | -25.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 42.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -4.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other EMEA | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other EMEA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|